There seem to be three different types of people involved in hallucinogen research — those who synthesize, characterize, and consume hallucinogenic substances; those who are passionate about rat brains, state-of-the-art agonists, and beta-ray radiography of thin slides of tissue after the administration of labeled ligands; and those who are engaged in the actual care and study of persons with schizophrenia. Apparently these three groups do not talk to each other, or at least not much.
Why is this a rationality quote? I have never seen a poorer state of interdisciplinary research than I have on the topic of ayahuasca. This quote is the closest I have seen to treatise on a topic about the poor state of information. This does an incredible disservice to everyone involved. Some people use the drug after reading the mainsteam psychologicl literature about it and it improves their mood and reduces anxiety. However, there are clinical cases of psychosis documented that are rarely cited. And why would they?
The mainstream lit example is a systematic review, the highest form of evidence. Meanwhile, a case study is the lowest. The thing is, I have read 100′s, yes 100′s of independent anecdotes of people expressing post-ayahuasca experiences amounting to precipitated drug induced psychoses, schizophrenia, schizotypal traits, psychoaffective symptoms, hppd and similar. Even if someone was to review these (which aren’t documented in a single place, like regular pharmacological side effects are), they would miss the countless cases where people report their symptoms in spiritual terms, due to the predominance of that kind of interpretation.
There is no criminal justice scholarship that isanti-ayahuasca, but it typically neglects the positive mental health experiences. It is clear that there is extreme variability of outcome, but I fear that this will not be identified in the future due to methodological disjunctions and seperate communities, plus disengagement with the user community by the medical fraternity since they don’t constitute a typically marginalised special population who attend addiction clinics or hospital settings.
At the frontier, however, I expect people who are otherwise excellent psychonauts would get severely diminished returns from ayahuasca. I, for one, had a harrowing but largely non particularly insightful or affectively or anxiety affecting experience with mushrooms (although it had some mild positive shifts to my personality—less neurotic, more open minded, less psychotic—concordant with the literature), and had no effect from smoked DMT. Anywho, People can authenetically lucid dream the ayahuasca experience. Discoveries occur in anecdotes and case reports, remember, never in secondary research and rarely in large studies, unless the effects are more subtle or interpersonal.
I have never seen a poorer state of interdisciplinary research than I have on the topic of ayahuasca.
I think that might be because in this case you have access to the accounts of psychonauts because the psychonautic community doesn’t have secrecy provisions.
In the field that have the poorest interdisciplinary research you don’t even know that knowledge exists somewhere because the people hold it in secret.
-Steve Beyer
Why is this a rationality quote? I have never seen a poorer state of interdisciplinary research than I have on the topic of ayahuasca. This quote is the closest I have seen to treatise on a topic about the poor state of information. This does an incredible disservice to everyone involved. Some people use the drug after reading the mainsteam psychologicl literature about it and it improves their mood and reduces anxiety. However, there are clinical cases of psychosis documented that are rarely cited. And why would they?
The mainstream lit example is a systematic review, the highest form of evidence. Meanwhile, a case study is the lowest. The thing is, I have read 100′s, yes 100′s of independent anecdotes of people expressing post-ayahuasca experiences amounting to precipitated drug induced psychoses, schizophrenia, schizotypal traits, psychoaffective symptoms, hppd and similar. Even if someone was to review these (which aren’t documented in a single place, like regular pharmacological side effects are), they would miss the countless cases where people report their symptoms in spiritual terms, due to the predominance of that kind of interpretation.
There is no criminal justice scholarship that is anti-ayahuasca, but it typically neglects the positive mental health experiences. It is clear that there is extreme variability of outcome, but I fear that this will not be identified in the future due to methodological disjunctions and seperate communities, plus disengagement with the user community by the medical fraternity since they don’t constitute a typically marginalised special population who attend addiction clinics or hospital settings.
At the frontier, however, I expect people who are otherwise excellent psychonauts would get severely diminished returns from ayahuasca. I, for one, had a harrowing but largely non particularly insightful or affectively or anxiety affecting experience with mushrooms (although it had some mild positive shifts to my personality—less neurotic, more open minded, less psychotic—concordant with the literature), and had no effect from smoked DMT. Anywho, People can authenetically lucid dream the ayahuasca experience. Discoveries occur in anecdotes and case reports, remember, never in secondary research and rarely in large studies, unless the effects are more subtle or interpersonal.
I think that might be because in this case you have access to the accounts of psychonauts because the psychonautic community doesn’t have secrecy provisions.
In the field that have the poorest interdisciplinary research you don’t even know that knowledge exists somewhere because the people hold it in secret.